1311.2.49005 Boehringer Ingelheim Investigational Site
Lübeck
0 studies enrolling now · 1 studies all time
What they study most
Psoriasis
Studies at this site
BI 655066 Dose Ranging in Psoriasis, Active Comparator Ustekinumab
— Completed